Individualized Brain Stimulation for Irritable Bowel Syndrome With Depressive Symptoms
Key facts
- Who runs it
- The Affiliated Hospital of Hangzhou Normal University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 1 Dec 2024
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Individualized Intermittent Theta-Burst Stimulation
- Sham Intermittent Theta-Burst Stimulation
- Record updated
- 16 November 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- Right-handed individuals
- Diagnosis of irritable bowel syndrome according to the Rome IV criteria
- Presence of depressive symptoms, defined as a HAMD-17 score greater than 7
- Inadequate response to at least two months of conventional treatment for IBS
- Ability to understand the study procedures and provide written informed consent
- Willingness and ability to undergo MRI examinations and complete the study assessments
Who cannot take part
- Known food intolerance, relevant gastrointestinal surgery, or gastrointestinal diseases other than IBS that may explain the symptoms
- History of significant neurological disorders or psychiatric disorders other than the depressive symptoms under investigation
- History of intracranial surgery
- Other conditions that, in the investigator's judgment, would make participation inappropriate or unsafe
- Contraindications to MRI or transcranial magnetic stimulation
- Intracranial mass lesions or severe white matter abnormalities detected by MRI
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Irritable bowel syndrome or depressive symptoms
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized, double-blind, sham-controlled trial aims to evaluate the effects of individualized intermittent theta-burst stimulation (iTBS) on depressive and gastrointestinal symptoms in patients with irritable bowel syndrome (IBS) and depressive symptoms.
Read full original descriptionShow less
A total of 60 eligible participants will be randomly assigned in a 1:1 ratio to active or sham stimulation. Individualized stimulation targets within the left dorsolateral prefrontal cortex (DLPFC) will be identified using resting-state functional magnetic resonance imaging (fMRI).
Participants will receive 10 stimulation sessions over two weeks. Clinical assessments and multimodal brain MRI will be performed at baseline and at the end of Week 2. The primary outcome will be the change in depressive symptom severity measured by the 17-item Hamilton Depression Rating Scale (HAMD-17).
An optional ancillary study involving paired stool sample collection at baseline and Week 2 is planned to support future exploratory investigations of gut microbiota and its associations with clinical symptoms and brain network characteristics. This ancillary component will be implemented only after the relevant ethics approval and additional informed consent have been obtained.
The 2 groups in the trial
- Active Individualized iTBSTreatment being tested
Participants will receive individualized intermittent theta-burst stimulation targeting the left dorsolateral prefrontal cortex. The stimulation target will be identified using resting-state fMRI-guided functional connectivity analysis. Stimulation will be delivered at 90% of the resting motor threshold, with 1,800 pulses per session. Each session will comprise three blocks of 600 pulses, separated by approximately 15-minute intervals. Participants will receive five sessions per week for two weeks, for a total of 10 sessions.
Treatment: Individualized Intermittent Theta-Burst Stimulation
- Sham iTBSSham treatment, for comparison
Participants will undergo a sham stimulation procedure with a schedule comparable to the active intervention. The stimulation coil will be positioned at 90 degrees to minimize effective cortical stimulation. Participants will receive five sessions per week for two weeks, for a total of 10 sessions.
Treatment: Sham Intermittent Theta-Burst Stimulation
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Individualized Resting-State fMRI-Guided Intermittent Theta-Burst Stimulation on Depressive and Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome: A Randomized, Double-Blind, Sham-Controlled Trial
- Criteria questions
- Built from NCT07939698, who can take part
- Record updated
- 16 November 2026